Login:
 
Lockyer M. Do 5 alpha-reductase inhibitors raise the risk of type 2 diabetes? Practitioner May 2019;263(1826):7

Do 5 alpha-reductase inhibitors raise the risk of type 2 diabetes?

22 May 2019Pais-up subscribers

Finasteride and dutasteride appear to be associated with a modest increase in the risk of developing type 2 diabetes, according to the findings of a retrospective cohort study.

Paid-up subscribersThis article can be accessed only if you are a paid-up subscriber to The Practitioner.

To view current online and print subscription rates, and to contact the subscription department, click Subscribe today .